On October 25, 2022, Jiangsu Kangweishi Biotechnology Co LTD. (hereinafter referred to as "Kangwei Century" was officially listed on the Science and Technology Innovation Board of Shanghai Stock Exchange securities code:688426Kone is acting as the issuer's counsel to provide legal services for the offering.
Since its establishment in 2010, Kangwei Century has focused on the independent research and development of the underlying core technology of molecular detection. realized the integrated layout of "core enzyme raw material +kit detection" service of molecular detection, and become one of the few domestic biotechnology enterprises that realize the complete business layout of the core links of molecular detection. Its core products include raw materials for molecular detection enzymes. nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The company and its team also participated in the drafting of many national standards, industry standards, group standards and national key research and development projects in the field of molecular detection.
